Seton Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SETON PHARMS, and what generic and branded alternatives to SETON PHARMS drugs are available?
SETON PHARMS has four approved drugs.
Summary for Seton Pharms
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Seton Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-001 | Oct 30, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-002 | Oct 30, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206667-001 | Apr 24, 2019 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
